AGMB
AgomAb Therapeutics NV American Depositary Shares
NASDAQ: AGMB · HEALTHCARE · BIOTECHNOLOGY
$10.74
+0.94% today
Updated 2026-04-29
Market cap
$528.92M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.50
Dividend yield
—
52W range
$9 – $17
Volume
0.2M
AgomAb Therapeutics NV American Depositary Shares (AGMB) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Gross margin | — | — | — | — |
| R&D | $19.42M | $26.31M | $39.31M | $39.31M |
| SG&A | $4.49M | $6.00M | $9.82M | $9.82M |
| Operating income | $-22.63M | $-31.19M | $-48.02M | $-48.02M |
| Operating margin | — | — | — | — |
| EBITDA | $-10.74M | $-11.88M | $-45.88M | $-45.88M |
| EBITDA margin | — | — | — | — |
| EBIT | $-10.76M | $-11.98M | $-46.20M | $-46.20M |
| Interest expense | $45000.00 | $31000.00 | $67000.00 | $67000.00 |
| Income tax | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-8.14M | $-11.39M | $-46.27M | $-46.27M |
| Net income growth (YoY) | — | -39.9% | -306.2% | +0.0% |
| Profit margin | — | — | — | — |